• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 7133
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/07/2023
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that shaft break occurred.The patient presented with coronary blockage.The 90% stenosed target lesion was located in the moderately tortuous and mildly calcified left anterior descending artery.A 2.00mm x 15mm emerge balloon catheter was advanced for dilation.The device came out completely without issue.However, after removing it from the body, the mid-point of the metal hypotube broke.The procedure was completed with 2.5 x 15 emerge balloon catheter.No patient complications were reported.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: returned product consisted of an emerge mr balloon catheter.The device was visually and microscopically examined.There was a separation of the hypotube 56.8 cm from the strain relief.The separation indicates the device was likely kinked prior to separation as the ends was oval in shape.There were numerous kinks to the hypotube.There was contrast in the inflation lumen and the balloon.There was blood in the guidewire lumen and the balloon was loosely folded.Product analysis confirmed the reported break as there was separation to the device.
 
Event or Problem Description
It was reported that shaft break occurred.The patient presented with coronary blockage.The 90% stenosed target lesion was located in the moderately tortuous and mildly calcified left anterior descending artery.A 2.00mm x 15mm emerge balloon catheter was advanced for dilation.The device came out completely without issue.However, after removing it from the body, the mid-point of the metal hypotube broke.The procedure was completed with 2.5 x 15 emerge balloon catheter.No patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EMERGE
Common Device Name
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
pmt 741 persiaran cassia selat
bandarcassia, pulau pinan 14110
MY   14110
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key17172055
Report Number2124215-2023-30555
Device Sequence Number12551259
Product Code LOX
UDI-Device Identifier08714729806196
UDI-Public08714729806196
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K113220
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 07/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/04/2025
Device Model Number7133
Device Catalogue Number7133
Device Lot Number0030465060
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 06/07/2023
Supplement Date Received by Manufacturer07/24/2023
Initial Report FDA Received Date06/21/2023
Supplement Report FDA Received Date07/25/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured11/02/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-